DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NICORETTE

« Back to Dashboard

Clinical Trials for Nicorette

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00139516	Chinese Community Smoking Cessation Project	Completed	National Heart, Lung, and Blood Institute (NHLBI)	N/A	The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00139516	Chinese Community Smoking Cessation Project	Completed	University of California, San Francisco	N/A	The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00158171	Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
NCT00174499	A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum	Completed	McNeil AB	Phase 4	The purpose of this research study is to evaluate the effects on existing tooth stain of nicotine gum. The study will enroll adults who have visible tooth staining.

Clinical Trial Conditions for Nicorette

Condition Name

Condition Name for Nicorette
Intervention	Trials
Tobacco Dependence	15
Smoking Cessation	7
Tobacco Use Disorder	7
Smoking	3

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nicorette
Intervention	Trials
Tobacco Use Disorder	22
Lung Diseases	1
Stress Disorders, Traumatic	1
Heart Diseases	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nicorette

Trials by Country

Trials by Country for Nicorette
Location	Trials
Sweden	12
United States	10
China	4
South Africa	2
Germany	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nicorette
Location	Trials
Nebraska	2
Minnesota	2
New Jersey	1
North Carolina	1
Wisconsin	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nicorette

Clinical Trial Phase

Clinical Trial Phase for Nicorette
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	1
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nicorette
Clinical Trial Phase	Trials
Completed	25
Recruiting	5
Active, not recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nicorette

Sponsor Name

Sponsor Name for Nicorette
Sponsor	Trials
McNeil AB	14
GlaxoSmithKline	3
VA Office of Research and Development	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nicorette
Sponsor	Trials
Industry	28
Other	16
NIH	4

Export unavailable in trial.
Subscribe for complete access.